GWAS-identified genetic variants associated with medication-assisted treatment outcomes in patients with opioid use disorder: a systematic review and meta-analysis protocol
DiscussionThis systematic review can hopefully inform the direction of future research, aiding in the development of a safer and more patient-centered treatment. It will be able to highlight genome-wide significant variants that are replicable and associated with MAT patient outcomes.Systematic review registrationThis systematic review protocol has been registered with the International Prospective Register of Systematic Reviews (PROSPERO) (registration ID CRD42020169121).
Source: Systematic Reviews - Category: International Medicine & Public Health Source Type: research
More News: Databases & Libraries | Genetics | International Medicine & Public Health | Overdose | Psychiatry | Science | Study